<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100725004443N28</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-11</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of self-care education with smartphone application on complications of stem cell  transplantation</public_title>
      <acronym></acronym>
      <scientific_title>The effect of self-care education with smartphone application on complications of stemcell  transplantation in  leukemic patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>104</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40602</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The samples will be selected by continuous sampling and the patients will be placed in two groups of control and intervention by Block Balanced Randomization (BBR). By using the free web site http://www.randomization.com/, the assignment sequence will take place.</study_design>
      <phase>N/A</phase>
      <hc_freetext>complications of stemcell transplantation in leukemic patients.</hc_freetext>
      <i_freetext>Intervention 1: Control group: For patients in the control group, routine care and routine training includes a pre-transplant group training session that is conducted through the lecture center at the transplantation center. Intervention 2: Intervention group: In Intervention group,  the researcher train the self-care education program with smart phone application in addition to the routine training of the transplantation center. this application  was made by the researcher and confirmed by four experts. we give the smartphone application to the  patient or his caregiver (in patients who need care) and  train them  how to use the application and practice with them and also their possible questions are answered.  if there is a problem or the question to answer them the researcher's mobile phone number is given to them.  also the patient's phone number will  be taken by the researcher and will be contacted by the investigator weekly at least 10 minutes in the morning or evening, in order to encourage the use of the educational application and respond to the patient's likely questions.This smartphone application includes: leukemia, treatment methods, familiarity with bone marrow transplantation and its stages of action, possible complications and self-care methods for these patients, training in appropriate post-transplant nutrition, training on how to control infection , Cleaning, bathing, hand washing, oral hygiene, the way and rate of meeting and communication with others and observing its principles, possible complications of the disease and methods for preventing complications and early diagnosis, relief of symptoms, control and prevention methods Nausea and vomiting, oral ulcers and mucositis, and anxiety control methods.this smartphone application are approved by four members of the faculty and transplantation department. During the intervention, which starts from the beginning of pre-transplant chemotherapy as a linkage regimen and  continue for up to three months after the transplantation, the questionnaire for transplantation complication will be completed Selectively in both control and intervention groups after two weeks, one and three months.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Jalal Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat St. Tohid Sq Tehran I.IRAN</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>jalalrezaei1989@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Masoumeh Zakeri Moghaddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing Midwifery ,Tehran University of Medical Sciences Nosrat st. Tohid sq Tehran I.IRAN</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>mzakerimo@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Have at least reading and writing skills
Age between 15 and 60 years
Having an Android mobile phone by a patient or his family
Lack of psychological disorders detected
Patients with leukemia candidates for stem cell transplantation</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The client is not simultaneously involved in another research as a research sample
The client does not want to use the application
If the client is from the medical staff
The client or his/her family has a history of bone marrow transplantation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C95.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Leukemia, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: For patients in the control group, routine care and routine training includes a pre-transplant group training session that is conducted through the lecture center at the transplantation center.</i_keyword>
      <i_keyword>Intervention group: In Intervention group,  the researcher train the self-care education program with smart phone application in addition to the routine training of the transplantation center. this application  was made by the researcher and confirmed by four experts. we give the smartphone application to the  patient or his caregiver (in patients who need care) and  train them  how to use the application and practice with them and also their possible questions are answered.  if there is a problem or the question to answer them the researcher's mobile phone number is given to them.  also the patient's phone number will  be taken by the researcher and will be contacted by the investigator weekly at least 10 minutes in the morning or evening, in order to encourage the use of the educational application and respond to the patient's likely questions.This smartphone application includes: leukemia, treatment methods, familiarity with bone marrow transplantation and its stages of action, possible complications and self-care methods for these patients, training in appropriate post-transplant nutrition, training on how to control infection , Cleaning, bathing, hand washing, oral hygiene, the way and rate of meeting and communication with others and observing its principles, possible complications of the disease and methods for preventing complications and early diagnosis, relief of symptoms, control and prevention methods Nausea and vomiting, oral ulcers and mucositis, and anxiety control methods.this smartphone application are approved by four members of the faculty and transplantation department. During the intervention, which starts from the beginning of pre-transplant chemotherapy as a linkage regimen and  continue for up to three months after the transplantation, the questionnaire for transplantation complication will be completed Selectively in both control and intervention groups after two weeks, one and three months.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety and depression(A score above 11 based on the Hospital Anxiety and Depression Scale). Timepoint: Two weeks, one and three months after the intervention. Method of measurement: Hospital Anxiety and Depression Scale.</prim_outcome>
      <prim_outcome>Nausea(Mild or Moderate or Severe by Scale). Timepoint: Two weeks, one and three months after the intervention. Method of measurement: Visual analogue scale (VAS).</prim_outcome>
      <prim_outcome>Vomiting(Mild or Moderate or Severe by Scale). Timepoint: Two weeks, one and three months after the intervention. Method of measurement: khavar oncology scale.</prim_outcome>
      <prim_outcome>Mucositis(Grade 0 to Grade 4 by scale). Timepoint: Two weeks, one and three months after the intervention. Method of measurement: Form of diagnosis and severity of mucositis.</prim_outcome>
      <prim_outcome>Infection(yes or no based on scale). Timepoint: One and three months after the intervention. Method of measurement: Clinical and laboratory signs and symptoms of infection in patients undergoing stem cell transplantation.</prim_outcome>
      <prim_outcome>Readmission. Timepoint: One and three months after the intervention. Method of measurement: Readmission Rate Form.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-19</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Office building of Tehran University of medical Sciences, Keshavarz St, Tehran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
